Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1;Expression de c-kit dans les carcinomes nasopharyngés nord africains, corrélations avec l'âge et LMP1

Cancer/Radiotherapie

Volumn 11, Issue 5, 2007, Pages 247-251

  Charfi, S ^a   Khabir, A ^a   Ayadi, L ^a   Mseddi, M ^a   Makni, H ^b   Gorbel, A ^a   Daoud, J ^a   Frikha, M ^a   Jlidi, R ^c   Busson, P ^d   Boudawara, T S ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c UNIVERSITY OF SFAX   (Tunisia)

^d UMR 8126   (France)

Author keywords

c kit; Epstein Barr virus; Nasopharyngeal carcinoma

Indexed keywords

LATENT MEMBRANE PROTEIN 1; STEM CELL FACTOR; COLORING AGENT; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; ONCOPROTEIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ADOLESCENT; ADULT; AGE; AGED; CANCER STAGING; CHILD; COMPARATIVE STUDY; EVALUATION; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TUNISIA; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; COLORING AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; TIME FACTORS; TUNISIA; VIRAL MATRIX PROTEINS;

EID: 34648827392     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2007.06.007     Document Type: Article

References (22)

1. Bar-Sela G., Arush M.W., Sabo E., Kuten A., Minkov I., and Ben-Izhak O. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults. Pediatr. Blood Cancer 44 (2005) 1-7
2. Bar-Sela G., Kuten A., Ben-Eliezer S., Gov-Ari E., and Ben-Izhac O. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach. Mod. Pathol. 16 (2003) 1035-1040
3. Bruce I.A., Slevin N.J., Homer J.J., McGown A.T., and Ward T.H. Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer. Anticancer Drugs 16 (2005) 719-726
4. Coindre J.M., Emile J.F., Monges G., Ranchere-Vince D., and Scoazec J.Y. Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Ann. Pathol. 25 (2005) 358-385
5. Daoud J., Toumi N., Bouaziz M., Ghorbel A., Jlidi R., Drira M.M., et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur. J. Cancer 39 (2003) 2349-2354
6. Duensing A., Heinrich M.C., Fletcher C.D., and Fletcher J.A. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest. 22 (2004) 106-116
7. Gibson P.C., and Cooper K. CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv. Anat. Pathol. 9 (2002) 65-69
8. Holst V.A., Marshall C.E., Moskaluk C.A., and Frierson Jr. H.F. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod. Pathol. 12 (1999) 956-960
9. Khabir A., Ghorbel M., Daoud J., Frikha M., Drira M.M., Laplanche A., et al. Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detec. Prev. 27 (2003) 250-255
10. Khabir A., Karray H., Rodriguez S., Rose M., Daoud J., Frikha M., et al. EBV latent protein I abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. J. Virol. 2 (2005) 39
11. Khabir A., Sellami S., Sakka M., Ghorbel A.M., Daoud J., Frikha M., et al. Contrasted frequencies of p53 accumulation in the two age groups of north African nasopharyngeal carcinomas. Clin. Cancer Res. 6 (2000) 3932-3936
12. Khanfir A., Frikha M., Ghorbel A., Karray H., Drira M.M., and Daoud J. Les cancers métastatiques du nasopharynx: étude clinique et résultats thérapeutiques de 95 cas. Cancer Radiother. 10 (2006) 545-549
13. Montone K.T., Van Belle P., Elenitsas R., and Elder D.E. Proto-oncogene c-Kit expression in malignant melanoma: protein loss with tumor progression. Mod. Pathol. 10 (1997) 939-944
14. Oertel S., Krempien R., Lindel K., Zabel A., Milker-Zabel S., Bischof M., et al. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Strahlenther. Onkol. 182 (2006) 400-407
15. Rivera S., Keryer C., Busson P., and Maingon P. Les carcinomes du nasopharynx : de la biologie à la clinique. Cancer Radiother. 9 (2005) 55-68
16. Scobie J.V., Acs G., Bandera C.A., Blank S.V., Wheeler J.E., Pasha T.L., et al. C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance. Int. J. Gynecol. Pathol. 22 (2003) 149-155
17. Sheu L.F., Lee W.C., Lee H.S., Kao W.Y., and Chen A. Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium. J. Pathol. 207 (2005) 216-223
18. Sheu L.F., Young Z.H., Lee W.C., Chen Y.F., Kao W.Y., and Chen A. STI571 sensitizes nasopharyngeal carcinoma cells to cisplatin: Sustained activation of ERK with improved growth inhibition. Int. J. Oncol. 30 (2007) 403-411
19. Simon R., Panussis S., Maurer R., Spichtin H., Glatz K., Tapia C., et al. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin. Cancer Res. 10 (2004) 178-183
20. Smithey B.E., Pappo A.S., and Hill D.A. C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am. J. Surg. Pathol. 26 (2002) 486-492
21. Tsuura Y., Hiraki H., Watanabe K., Igarashi S., Shimamura K., Fukuda T., et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma, and seminoma/dysgerminoma in human: immunohistochemical study of formalin-fixed, paraffin-embedded tissues. Virchows Arch. 424 (1994) 135-141
22. Wang-Rodriguez J., Lopez J.P., Altuna X., Chu T.S., Weisman R.A., and Ongkeko W.M. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro. Laryngoscope 116 (2006) 1409-1416